BASEL, Switzerland, May 20, 2021 /PRNewswire/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading clinical stage psychedelic medicine company, announced today the approval by the local Swiss ...
Over the past two decades, researchers have published study after study evaluating the therapeutic potential of psychedelics like psilocybin and LSD. The research is so promising that despite being ...
Lysergic acid diethylamide (LSD), psilocybin (the psychoactive compound in “magic mushrooms”) and mescaline are three of the most widely studied classic psychedelics. Each has a long history of ...
There’s something about mescaline. Prehistoric desert dwellers of the American Southwest and Mexico figured as much out when they figured out that eating peyote — the small, spineless cactus dotting ...
NAPANEE, Ontario, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Lophos Holdings Inc. ("Lophos", or the "Company") (CSE:MESC) is thrilled to provide further insights into the accomplishments of its wholly-owned ...
Like many a researcher before him (including the late great Havelock Ellis), British Psychiatrist John Smythies was fascinated by the extraordinary visions he had after taking mescaline, an alkaloid ...
Mescaline: A Global History of the First Psychedelic. By Mike Jay.Yale University Press; 304 pages; $26 and £18.99. MESCALINE IS THE drug that launched the modern fascination with hallucinogens. It is ...
BASEL, Switzerland, May 20, 2021 /CNW/ -- MindMed (Nasdaq: MNMD) (NEO: MMED) (DE: MMQ), a leading clinical stage psychedelic medicine company, announced today the approval by the local Swiss ethics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results